A 12 Week, Open Label, Phase I/IIa Study Using Apatone<sup>®</sup> for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy - Concepedia

Concepedia

Publication | Open Access

A 12 Week, Open Label, Phase I/IIa Study Using Apatone<sup>®</sup> for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy

DOI Full Paper Access

65

Citations

18

References

2008

Year

Basir Tareen, Jack L. Summers, James M. Jamison, Deborah R. Neal, Karen McGuire, Lowell W. Gerson, Ananias C. Diokno

International Journal of Medical Sciences

Abstract

Apatone showed promise in delaying biochemical progression in this group of end stage prostate cancer patients.

References

	Year	Citations

Page 1